At present, the treatment of gout is mainly based on medication. Due to the severity of the disease and the responsiveness of patients to treatment drugs, there is no specific value for the cost of gout treatment, and the cost of treatment varies from patient to patient. For gout patients in the acute stage, non-steroidal anti-inflammatory painkillers, colchicine and glucocorticoids are mainly used to reduce the inflammatory response and improve joint symptoms. The price of these drugs is not high, and the course of treatment in the acute stage of gout is relatively short, so the overall economic cost is not high. Patients in the intermittent and remission phases need uric acid inhibitors or uric acid excretors. Most of these drugs are moderately priced, while a few are more expensive, but the overall cost is higher than in the acute phase because of the longer treatment period. For patients with pre-existing gout stones or renal complications, in addition to conventional treatment, relevant treatment is required depending on the extent of the condition. For example, if there are huge gout stones that need to be removed surgically, or if there are serious deformities of the joints that need to be corrected surgically, the financial cost increases accordingly and is not easy to predict. However, this type of treatment is unconventional and is rarely used in general clinical practice except for special patients. Therefore, overall, the overall cost of gout treatment is moderate, the price of conventional treatment drugs is moderate, and critical complications are generally rare.